Loading the security page…
The series is stated in the current share scale after splits; dividends are not included in the price
Baxter makes infusion pumps, intravenous solutions and dialysis equipment — the consumables of a hospital ward.
The products are literally everyday: saline, intravenous sets, pumps standing by every bed. That means a low mark-up at enormous volume, and the result depends on manufacturing and logistics efficiency more than on product novelty.
Nature exposed the vulnerability: a hurricane that damaged a large solutions plant caused a nationwide shortage and forced hospitals to postpone elective surgery — manufacturing concentration proved a risk beyond the company itself. It spun the kidney care line into a separate structure and is reducing debt. Risks: hospital reimbursement, costs and manufacturing quality. A dividend is paid.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Baxter International Inc. (BAX) is a company in the Health care sector; its shares trade on NYSE.
The price of Baxter International Inc. (BAX) on October 30, 2026 is 22.80 $, −2.96 % on the day. Over 52 weeks the stock traded between 15.73 $ and 30.00 $; the price now sits 50 % of the way up that range. Over the past year the price changed by +13.23 %. Market capitalization is 11.79 billion $, rank 12 among 100 stocks of the same industry with a known capitalization.
Baxter International Inc. trades on NYSE under the ticker BAX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BAX has traded between 15.73 $ and 30.00 $. As of 30 October 2026 the price stood 70.29 % of the way from the 52-week low to the high.
Over one year BAX shares rose 13.23 %; over six months they rose 42.01 %. Volatility over 90 days is 38.06 %. Dividends are not included: this is price change only, as of 30 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.0, below the sector median of 3.6. Price to book is 1.9, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Baxter International Inc. reported revenue of 11.5B $ and a net loss of 1.1B $ over the last four quarters. Net margin is −9.27 %. Revenue changed by +5.36 % year over year. Earnings per share are −2.08 $. Market capitalisation is 11.8B $.
BAX has a return on equity of −17.13 %, above the sector median of −40.58 %. Return on assets is −5.37 %, above the sector median of −30.08 %. Operating margin is −2.39 %, above the sector median of −20.96 %.